WHO Suspends Hydroxychloroquine Clinical Trials... "No Effect"

Lopinavir·Ritonavir Trials Also Halted

[Asia Economy Reporter Naju-seok] The World Health Organization (WHO) has decided to halt clinical trials of hydroxychloroquine, a drug that had attracted attention as a potential game changer in the treatment of the novel coronavirus disease (COVID-19). The results of experiments conducted on patients infected with COVID-19 showed no significant effect.

Medical staff are holding hydroxychloroquine.
Photo by Reuters Yonhap News

On the 5th (local time), WHO announced that clinical trial results for hydroxychloroquine did not demonstrate a reduction in mortality compared to standard treatments. Hydroxychloroquine gained attention after U.S. President Donald Trump claimed it could be a game changer in COVID-19 treatment and reportedly took the drug himself.

This decision was made based on a comparative analysis of treatment outcomes between patients who took hydroxychloroquine and those who did not.

WHO also announced the suspension of trials for the HIV treatment drugs lopinavir and ritonavir.

This content was produced with the assistance of AI translation services.